Greg Norden

Greg Norden is the former Chief Financial Officer of Wyeth. Greg also serves on the Boards of Zoetis, the leading animal health company; NanoString, a leading provider of life science tools for translational medicine; and Praxis, a clinical-stage biopharmaceutical company. Greg is a former director of Human Genome Sciences, Univision and Welch Allyn. In addition, Greg is the Managing Director of G9 Capital Group, LLC, which invests in early stage ventures and provides corporate advisory services. Greg has a B.S. in Management and Economics from State University of New York at Plattsburgh and an M.S. in Accounting from LIU Post.

Stay up to date

Subscribe to Royalty Pharma news and alerts

Subscribe